Karyopharm Therapeutics
KPTI
$1.10
Share price
3.77%
Change (1 day)
-71.43%
Change (1 year)
Categories
Karyopharm Therapeutics (KPTI) - Total debt
Total debt on the balance sheet as of December 2023 : $0.17 B
According to Karyopharm Therapeutics 's latest financial reports the company's total debt is $0.17 B. A company’s total debt is the sum of all current and non-current debts.
Karyopharm Therapeutics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | -1.15% |
| 2022-12-31 | $0.17 B | -0.83% |
| 2021-12-31 | $0.18 B | 37.71% |
| 2020-12-31 | $0.13 B | 5.15% |
| 2019-12-31 | $0.12 B | 21.47% |
| 2018-12-31 | $0.10 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $15.62 B | 8,728.58% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 19,703.29% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 32,331.53% | 🇺🇸 USA |
 Exelixis EXEL | $0.18 B | 7.30% | 🇺🇸 USA |